DWGCX
Price
$10.68
Change
-$0.08 (-0.74%)
Updated
Nov 13 closing price
RNWEX
Price
$80.75
Change
-$0.65 (-0.80%)
Updated
Nov 13 closing price
Ad is loading...

DWGCX vs RNWEX

Header iconDWGCX vs RNWEX Comparison
Open Charts DWGCX vs RNWEXBanner chart's image
American Funds Dvlpg Wld Gr&Inc C
Price$10.68
Change-$0.08 (-0.74%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$80.75
Change-$0.65 (-0.80%)
VolumeN/A
CapitalizationN/A
DWGCX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DWGCX vs. RNWEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWGCX is a Sell and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 62.3B vs. DWGCX (1.86B). RNWEX pays higher dividends than DWGCX: RNWEX (1.24) vs DWGCX (0.99). DWGCX was incepted earlier than RNWEX: DWGCX (11 years) vs RNWEX (22 years). DWGCX is a more actively managed with annual turnover of: 37.00 vs. RNWEX (32.00). DWGCX (250) and RNWEX (250) have matching initial minimum investment requirements. RNWEX annual gain was more profitable for investors over the last year : 13.19 vs. DWGCX (10.47). RNWEX return over 5 years is better than : 17.93 vs. DWGCX (2.13).
DWGCXRNWEXDWGCX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD4.9448.38959%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B62.3B3%
Annual Yield % from dividends0.991.2480%
Returns for 1 year10.4713.1979%
Returns for 3 years-16.67-13.68122%
Returns for 5 years2.1317.9312%
Returns for 10 years3.0141.347%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DORM137.85-0.15
-0.11%
Dorman Products
TEVA16.94-0.17
-0.99%
Teva Pharmaceutical Industries Limited
CAPR16.91-1.19
-6.57%
Capricor Therapeutics
GEVO1.42-0.22
-13.41%
Gevo
OLB2.01-0.40
-16.46%
OLB Group Inc. (The)